Emmaus Life Sciences, Inc. SEC filings EMMA

Emmaus Life Sciences, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Sep 2, 2009. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 31, 2026 Dec 31, 2025
10-K Annual report Apr 14, 2025 Dec 31, 2024
10-K Annual report Jul 3, 2024 Dec 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K/A Amended annual report Jul 1, 2022 Dec 31, 2021
10-K Annual report Mar 31, 2022 Dec 31, 2021
10-K/A Amended annual report Aug 10, 2021 Dec 31, 2020
10-K Annual report May 4, 2021 Dec 31, 2020
10-K Annual report Jan 25, 2021 Dec 31, 2019
10-K Annual report Dec 11, 2018 Sep 30, 2018
10-K Annual report Dec 29, 2017 Sep 30, 2017
10-K Annual report Dec 22, 2016 Sep 30, 2016
10-K Annual report Jan 5, 2016 Sep 30, 2015
10-K/A Amended annual report Jan 23, 2015 Sep 30, 2014
10-K Annual report Dec 29, 2014 Sep 30, 2014
ARS Annual report to shareholders Apr 24, 2014 Sep 30, 2013
10-K/A Amended annual report Jan 28, 2014 Sep 30, 2013
10-K Annual report Dec 23, 2013 Sep 30, 2013
10-K/A Amended annual report Jan 28, 2013 Sep 30, 2012
10-K Annual report Jan 15, 2013 Sep 30, 2012
10-K Annual report Dec 22, 2011 Sep 30, 2011
10-K Annual report Dec 21, 2010 Sep 30, 2010
10-K/A Amended annual report Mar 30, 2010 Sep 30, 2009
10-K/A Amended annual report Jan 25, 2010 Sep 30, 2009
10-K Annual report Dec 30, 2009 Sep 30, 2009

Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
EMMA (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Torrance, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
822370
Former names
MYnd Analytics, Inc. (until Jul 12, 2019); CNS RESPONSE, INC. (until Dec 10, 2015); STRATIVATION, INC. (until Mar 1, 2007); SalesTactix, Inc. (until Aug 23, 2005); AGE RESEARCH INC (until Aug 5, 2004)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.